Page last updated: 2024-09-04

m 8218 and Brain Ischemia

m 8218 has been researched along with Brain Ischemia in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gu, SL; Hu, B; Ma, TF; Ma, X; Qin, SJ; Wang, Y; Yan, JZ; Zhang, Y; Zhou, CH; Zhou, L1
Gu, PF; Li, Y; Shang, Y1

Other Studies

2 other study(ies) available for m 8218 and Brain Ischemia

ArticleYear
A selective M1 and M3 receptor antagonist, penehyclidine hydrochloride, prevents postischemic LTP: involvement of NMDA receptors.
    Synapse (New York, N.Y.), 2013, Volume: 67, Issue:12

    Topics: Animals; Brain Ischemia; Hippocampus; Long-Term Potentiation; Male; Neuroprotective Agents; Potassium Channel Blockers; Protein Kinase C; Quinuclidines; Rats; Rats, Sprague-Dawley; Receptor, Muscarinic M1; Receptor, Muscarinic M3; Receptors, N-Methyl-D-Aspartate; Scopolamine; Small-Conductance Calcium-Activated Potassium Channels

2013
[Penehyclidine hydrochloride inhibits glutamate release and related research in global brain ischemia/reperfusion rats].
    Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology, 2011, Volume: 27, Issue:3

    Topics: Animals; Brain Ischemia; CA1 Region, Hippocampal; Cholinergic Antagonists; Glutamic Acid; Male; Quinuclidines; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Reperfusion Injury

2011